News & Events

On January 17, 2018, Richard E. Engler, Ph.D., Senior Chemist at The Acta Group (Acta®), was quoted by NBC News in the article “EPA eases path for new chemicals, raising fears of health hazards.” The EPA’s new approach is likely to reduce the testing that manufacturers who first bring these new chemicals to market are required to do. Using significant new-use rules (SNURs) “reduces the testing that the EPA is seeking to impose, because testing is rarely...

On January 10, 2018, the Bloomberg BNA Daily Environment Report covered the TSCA New Chemicals Coalition’s (NCC) response to a federal court challenge by the Natural Resources Defense Council (NRDC) against the U.S. Environmental Protection Agency's (EPA) New Chemicals Decision-Making Framework. The New Chemicals Coalition, which Bergeson & Campbell P.C. launched in 2017 as a forum for companies interested in bringing new chemicals to market, has not decided whether or...

On January 4, 2018, the TSCAblog™ post “In Case of First Impression, Court Rules EPA Wrongly Dismissed Citizen Group’s TSCA Section 21 Petition” was quoted by Inside EPA in an article discussing the U.S. Environmental Protection Agency’s (EPA) Toxic Substances Control Act (TSCA) Section 21 ruling on flouride.  The law firm Bergeson & Campbell describes the ruling as a “fairly scathing rebuke of EPA’s legal positions,” in a Dec. 22 blog post,...

The Acta Group (Acta®) was featured in the Winter 2017 Elements Magazine, published quarterly by Chemicals Northwest as a “one-stop solution” for global or local chemical regulatory compliance, especially for companies preparing for the May 13, 2018 Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) deadline. Acta has frequently received recognition from clients and industry globally for our previous and ongoing demonstrations of excellence,...

On December 19, 2017,  Bloomberg BNA Daily Environment Report included comments by Michael S. Wenk, M.S., Senior Regulatory Consultant with The Acta Group (Acta®), regarding future chemical regulations in Brazil. Big questions remain, among them: Will Brazil recognize industrial chemicals registered through other systems like the Toxic Substances Control Act in the U.S., or REACH in the European Union? Or will companies have to reproduce testing results? Even when...

On December 18, 2017, Lynn L. Bergeson, President of The Acta Group (Acta®), was quoted by the Bloomberg BNA Daily Environment Report in the article “FDA Pushes Risk-Based Approach to Nanomaterial Drugs.” Developers of drugs containing nanomaterials—substances so small they can't be seen with a regular microscope—got some advice on how to assess their risks in FDA draft guidance issued Dec. 15. […] Without having read it in detail yet, Lynn Bergeson, managing...

On December 15, 2017, Chemical Watch featured comments by the TSCA New Chemicals Coalition (NCC) on the U.S. Environmental Protection Agency’s (EPA) new chemical evaluation policy. An industry group has argued that the US EPA should avoid issuing orders to mitigate workplace risks associated with new chemicals. Instead, it says, it should turn over that regulatory responsibility to the Occupational Health and Safety Administration (Osha). The TSCA New Chemicals...

On December 11, 2017, Lynn L. Bergeson, President of The Acta Group (Acta®), was quoted in the Chemical Week article “Trump's EPA: TSCA remains priority amid regulatory rollback.” “Not surprisingly, there’s been a tremendous focus on the implementation requirements for Lautenberg,” says Lynn Bergeson, managing partner of Bergeson & Campbell (Washington, DC). Efforts have included building a conceptual framework of how to review and apply the new standards...

On December 11, 2017, Richard E. Engler, Ph.D., Senior Chemist at The Acta Group (Acta®), was quoted in Chemical Watch regarding concerns with the U.S. Environmental Protection Agency’s (EPA) plan to move away from consent orders in favor of Significant New Use Rules (SNURs) when regulating potential uses of new chemicals. When the situation described in a pre-manufacture notice (PMN) is not of concern, but there is a potential use of the new chemical that would raise...

The Acta Group (Acta®) and Bergeson & Campbell, P.C. (B&C®) are pleased to announce that Scott J. Burya, Ph.D. has joined our firms as a Regulatory Chemist.  Dr. Burya holds a Ph.D. in analytical chemistry from the Ohio State University and will support clients in all stages of product development, from assessing the toxicology and regulatory profiles of new substances, performing quantitative risk assessments, and navigating state and federal...